This is best demonstrated by the IHC data, where the combination group has consistently higher levels of inflammation and of CD8+ cells infiltrating the tumor parenchyma compared to the IFN+5Aza and vaccine alone groups. The gene discussed is CD8A; the disease is neoplasm.